On August 2, 2026, leading oncology networks discussed patient access strategies for fibroblast growth factor receptor (FGFR) inhibitors in the United States. For patients diagnosed with unresectable, locally advanced, or metastatic cholangiocarcinoma (bile duct cancer) harboring susceptible FGFR2 fusions or rearrangements, sourcing target therapies like Lucinfig (Infigratinib) 100mg Capsules 21's is a crucial step in maintaining treatment progression.

At Critical Kare Pharma, we cooperate with international supply corridors to deliver authentic, batch-verified specialty oncology medications to patients and clinics across the USA. Sourcing through validated networks provides a clear, documented path to clinical continuity.

FGFR Inhibitors in Cholangiocarcinoma Care

Cholangiocarcinoma is a rare and aggressive malignancy of the bile ducts. Precision oncology utilizes genetic profiling to identify actionable mutations. When FGFR2 rearrangements are present, targeted inhibitors like Infigratinib offer a critical line of defense:

• Targeted Tyrosine Kinase Action: Infigratinib selectively binds to and inhibits FGFR2, halting downstream phosphorylation pathways that drive tumor cell growth and proliferation.
• Oral Capsule Convenience: Administered orally, allowing patients to undergo targeted therapy at home, minimizing frequent hospital stays.
• Dosage and Administration: Lucinfig 100mg is typically taken once daily for 21 consecutive days followed by 7 days off, completing a 28-day cycle. It must be taken on an empty stomach, either 1 hour before or 2 hours after a meal.

U.S. FDA Personal Importation and Compliance

Since the commercial availability of certain brand-name FGFR inhibitors has shifted, patients in the United States often utilize personal importation pathways to source authentic alternatives. Sourcing personal supplies requires strict adherence to regulatory standards to ensure package clearance:

• Oncologist Prescription: A valid medical prescription from a U.S.-licensed oncologist is mandatory. It must specify the patient’s diagnosis (FGFR2-positive cholangiocarcinoma) and detailed dosage.
• 90-Day Limitation: U.S. Customs and Border Protection (CBP) and the FDA enforce a strict 90-day personal supply limit for imported prescription medications.
• Documentation Standards: Every parcel must contain a complete document pack, including a Certificate of Analysis (COA) from the manufacturer, commercial purchase invoice, and the physician's prescription.

Critical Kare Pharma handles the complex customs paperwork and coordinates GDP-compliant shipping to ensure secure, timely delivery to your address in the United States.